Linking autophagy with inflammation through IRF1 signaling in ER+ breast cancer

Resistance to antiestrogen therapy remains a critical determinant of mortality in patients affected by ER+ breast cancer. Our previous work identified autophagy and interferon regulatory factor 1 (IRF1) signaling as key regulators of this process. We have recently demonstrated a novel reciprocal interaction between IRF1 and ATG7, linking inflammation and autophagy.

[1]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[2]  R. Clarke,et al.  The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer , 2011, International journal of breast cancer.

[3]  C. Mathieu,et al.  The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells. , 1999, European cytokine network.

[4]  Michelle L Bowie,et al.  Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells , 2004, Oncogene.

[5]  Robert Clarke,et al.  Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. , 2012, Cancer research.

[6]  Robert Clarke,et al.  Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate. , 2015, Cancer research.

[7]  M. Dowsett,et al.  International Web-based consultation on priorities for translational breast cancer research , 2007, Breast Cancer Research.

[8]  R. Clarke,et al.  Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer , 2014, Clinical Cancer Research.

[9]  W. Baumann,et al.  Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. , 2012, Cancer research.

[10]  S. Kawachi,et al.  Abstract 1321: A novel prevention method against re-obstruction of titanium alloy stent for biliary malignancy using generation of hydroxyl radical under ultrasonic irradiation , 2012 .

[11]  L. Papa,et al.  Bortezomib Enhances the Efficacy of Fulvestrant by Amplifying the Aggregation of the Estrogen Receptor, Which Leads to a Proapoptotic Unfolded Protein Response , 2011, Clinical Cancer Research.

[12]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[13]  Timothy R Billiar,et al.  IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo , 2004, Oncogene.